6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prolonged post-operative course in children treated with inhaled nitric oxide for pulmonary hypertension after closure of a ventricular septal defect

, , , &
Pages 67-71 | Published online: 04 Dec 2011

References

  • Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br. Heart J. 1995; 73: 65–68.
  • Wessel DL, Adatia I. Clinical applications of inhaled nitric oxide in children with pulmonary hypertension. Adv. Pharmacol. 1995; 34: 475–504.
  • Friedli B, Kidd BS, Mustard WT, Keith JD. Ventricular septal defect with increased pulmonary vascular resistance. Late results of surgical closure. Am. J. Cardiol. 1974; 33: 403–409.
  • Blackstone EH, Kirklin JW, Bradley EL, Du Shane EW, Abman SH. Optimal age and results in repair of large ventricular septal defects. J. Thorac. Cardiovasc. Surg. 1979; 72: 661–679.
  • Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of Inhaled Nitric Oxide and Acetylcholine in the Evaluation of Pulmonary Hypertension and Endothelial Function After Cardiopulmonary Bypass. Circulation 1993; 88: 2128–2138.
  • Morray JP, Lynn AM, Mansfield PB. Effect of pH and PCO2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension. J. Pediatr. 1988; 113: 474–479.
  • Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit. Care Med. 2000; 28: 2974–2978.
  • Cueto E, Lopez-Herce J, Sanchez A, Carrillo A. Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr. 1997; 86: 1337–1339.
  • Buga GM, Griscavage JIM, Rogers NE, Ignarro U. Negative Feedback Regulation of Endothelial Cell Function by Nitric Oxide. Circ. Res. 1993; 73: 808–812.
  • Ma X-L, Lopez BL, Christopher TA, Birenbaum DS, Vinten-Johansen J. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. Physiol. 1996; 271: H2045–H2051.
  • Ravichandran LV, Johns RA, Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am. J. Physiol. 1995; 268: H2216–H2223.
  • Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann. Thorac. Surg. 1996; 62: 1759–1764.
  • Petros AJ. Down-regulation of endogenous nitric oxide production after prolonged administration. Lancet 1994; 344: 191–191.
  • Aly H, Sahni R, Wung JT. Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn. Arch. Dis. Child Fetal Neonatal Ed. 1997; 76: F118–F122.
  • Al-Alaiyan S, Al-Omran A, Dyer D. The use of phospho-diesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide. Intensive Care Med. 1996; 22: 1093–1095.
  • Ivy DD, Kinsella JP, Ziegler JW, Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J. Thorac. Cardiovasc. Surg. 1998; 115: 875–882.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.